###begin article-title 0
Variation of the Myelin Oligodendrocyte Glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 491 495 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
Multiple sclerosis (MS) is consistently associated with particular HLA-DRB1-DQB1 haplotypes. However, existing evidence suggests that variation at these loci does not entirely explain association of the HLA region with the disease. The MOG locus is a prime positional and functional candidate for such additional predisposing effects but the analysis is complicated by the strong, albeit labyrinthine pattern of linkage disequilibrium in the region. Here we have assessed the association of MOG variation with MS in the Sardinian population to see if it represents an independent contributor to MS predisposition.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 699 704 699 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
After re-sequencing the MOG gene in 21 healthy parents of MS patients we detected 134 variants, 33 of which were novel. A set of 40 informative SNPs was then selected and assessed for disease association together with 1 intragenic microsatellite in an initial data set of 239 MS families. This microsatellite and 11 SNPs were found to be positively associated with MS, using the transmission disequilibrium test, and were followed up in an additional 158 families (total families analysed = 397). While in these 397 families, 8 markers showed significant association with MS, through conditional tests we determined that these MOG variants were not associated with MS independently of the main DRB1-DQB1 disease associations.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
These results indicate that variation within the MOG gene is not an important independent determinant of MS-inherited risk in the Sardinian population.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 723 724 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 939 940 939 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1177 1178 1177 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1230 1235 1230 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 1239 1244 1239 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 1357 1371 1357 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA DRB1-DQB1 </italic>
###xml 1458 1463 1458 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 1470 1472 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1682 1687 1682 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 1688 1690 1688 1690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1947 1949 1947 1949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2069 2071 2069 2071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 2072 2074 2072 2074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 2075 2077 2075 2077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2098 2099 2098 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 2100 2101 2100 2101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 2102 2104 2102 2104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2105 2107 2105 2107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2134 2144 2134 2144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 2453 2457 2453 2457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 2458 2463 2458 2463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 2473 2475 2473 2475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2476 2478 2476 2478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2479 2481 2479 2481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2760 2764 2760 2764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 2868 2873 2868 2873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 2973 2983 2973 2983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 2984 2986 2984 2986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 3133 3135 3133 3135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 3136 3138 3136 3138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 3242 3244 3242 3244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 3245 3247 3245 3247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 3280 3284 3280 3284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 3347 3349 3347 3349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 3389 3391 3389 3391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 3392 3394 3392 3394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 3484 3488 3484 3488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 503 510 <span type="species:ncbi:9606">patient</span>
###xml 3157 3165 <span type="species:ncbi:9606">patients</span>
###xml 3337 3345 <span type="species:ncbi:9606">patients</span>
Multiple sclerosis (MS) is a serious chronic inflammatory and demyelinizating disorder of the central nervous system which results from an autoimmune attack on components of the oligodendrocyte cell [1]. The disease is more common in European and European-derived populations. Within Europe it shows a north-south gradient, with the notable exception of the Mediterranean island of Sardinia, which has one of the highest prevalences worldwide [2]. The disease risk for a monozygotic twin of an affected patient is about 30%, showing a quick fall-off rate with decreased genetic relatedness to affected individuals. These data, and the increasing incidence of disease reported in some populations over the last few decades [3,4], suggest that the chance of this inflammatory process occurring depends on the complex interplay between a polygenic trait and unknown environmental factors influencing the penetrance of susceptibility genes [5,6]. MS has been found to be consistently associated with specific HLA class II variants and notably with the HLA-DRB1*1501-DQB1*0602 haplotype, which represents the main risk factor for disease occurrence in different ethnic backgrounds [7-11]. The relative contribution of variation at the DRB1 and DQB1 loci to disease predisposition is still not completely clear although some studies based on cross-comparing rare HLA DRB1-DQB1 haplotype splits have indicated that the main contribution comes from variation at the DRB1 locus [11]. Analysis of large data sets from Finland and Canada have also suggested that in those populations, any important additional modifiers of MS susceptibility were likely to be contained in the regions close to DRB1 [12]. In Sardinia, the HLA-DRB1*1501-DQB1*0602 haplotype is rare but is still significantly positively associated with MS together with an additional 4 haplotypes including DRB1*1303-DQB1*0301, DRB1*0405-DQB1*0301, DRB1*0301-DQB1*0201 and DRB1*0405-DQB1*0302 [13]. Some of these haplotypes, such as DRB1*0301-DQB1*0201 are also associated with MS in some non-Sardinian populations [11,14,15] but not in others [8,9,16-20]. The presence of HLA non-DRB1-DQB1 predisposing effects related to a different distribution of extended HLA-DRB1*0301-DQB1*0201 haplotypes in different populations can explain these findings. Indeed, some studies have suggested that within the HLA region there are further independent predisposing effects determined by as yet unidentified non-DRB1-DQB1 variants [13,21-24]. However, strong linkage disequilibrium (LD) between the variants contained in the HLA region makes it difficult to detect which polymorphisms, outside the exon 2 sequences of the DR/DQ loci but within the HLA region, further influence disease risk. Within the HLA region, the MOG gene is a prime candidate for additional MS associations. This gene is located, 2.9 Mb telomeric of the DRB1 locus, in a chromosome interval which has shown some evidence of association with MS independent of DRB1-DQB1 [13]. Furthermore, the rodent ortholog of this gene encodes for an autoantigen which triggers autoimmune responses in experimental models of disease [25,26]. Moreover, in MS patients both T-cell and antibody responses against this protein have been detected [27,28] and an aetiologic role of anti-MOG antibodies has been suggested in acute lesions of MS patients [29], although this role is controversial [30,31]. These findings could be consistent with a model in which specific polymorphisms in the MOG gene could determine amino acid variation or differences in the level of expression of this protein in the central nervous system and affect immune responses against it, thus acting as primary aetiologic determinants of disease pathogenesis.
###end p 9
###begin p 10
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 415 429 415 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1-MOG </italic>
A few studies have tested the association between MOG polymorphisms and disease, with conflicting results. Some of these studies indicated a potential role of MOG [32,33] while others failed to find any evidence of primary association with MS [34,35,12]. However, none of these studies analysed the MOG gene comprehensively, nor assessed the association of genetic variation of this gene in the context of extended DRB1-DQB1-MOG haplotypes.
###end p 10
###begin p 11
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
The aim of this study was to establish the SNP content of the MOG gene in the Sardinian population and use this information together with appropriate conditional association tests to assess the individual contribution of the MOG gene to MS inherited risk to determine if it is an important independent risk locus.
###end p 11
###begin title 12
Results and discussion
###end title 12
###begin p 13
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 636 639 636 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r2 </italic>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 826 829 826 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG</italic>
###xml 885 886 885 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 888 889 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1134 1137 1134 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DR </italic>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1153 1155 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1262 1265 1262 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r2 </italic>
###xml 1365 1366 1365 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
###xml 711 719 <span type="species:ncbi:9606">patients</span>
In order to assess the association of MOG variation with MS we first established polymorphism content of the MOG gene in the Sardinian population by resequencing the gene in 21 healthy parents of MS patients. The primers used are listed in Table 1, and technical details are reported in the Methods section. We detected 134 SNPs, 101 of which had already been reported [36] and 33 were novel. A set of 40 informative SNPs was then selected to be tested for disease association (see Methods). These were initially genotyped in a data set of 239 MS families. To identify the haplotype-tagging patterns, we computed the intermarker D' and r2 values of these 40 informative SNPs, computed for 478 parents of the MS patients, shown in Figure 1. The physical positions, with base 1165 corresponding to the translation start site of MOG, and other relevant information are indicated in Table 2. D' values indicate that these SNPs are part of the same linkage disequilibrium block (average 0.97 between contiguous marker pairs) that, as we have previously shown, encompasses HLA class I and III sub-regions and also includes the HLA class II DR and DQ loci [37,13]. As expected, considering selected SNPs were chosen in order to avoid genetically redundant markers, the r2 values showed relatively low values with an average of 0.13 between contiguous marker pairs (Figure 1).
###end p 13
###begin p 14
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r2 </italic>
###xml 23 24 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
Distribution of r2 and D' intermarker values (above and below the diagonal respectively) for 40 SNPs analysed in 478 parents of Sardinian MS patients.
###end p 14
###begin p 15
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG51 </italic>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 475 481 475 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG51 </italic>
###xml 798 799 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 954 956 954 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 967 969 967 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-6</sup>
###xml 1056 1061 1056 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 1062 1064 1062 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1074 1076 1074 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7</sup>
###xml 1083 1088 1083 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 1112 1114 1112 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1124 1126 1124 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7</sup>
###xml 1220 1234 1220 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1-MOG </italic>
###xml 1293 1294 1293 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1309 1313 1309 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 1338 1348 1338 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 1863 1877 1863 1877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1-DQB1 </italic>
###xml 1915 1919 1915 1919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 1943 1953 1943 1953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 2055 2057 2055 2057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 2117 2121 2117 2121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 2223 2233 2223 2233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 2266 2276 2266 2276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 2371 2380 2371 2380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1</italic>
###xml 2381 2385 2381 2385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 2493 2494 2493 2494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 2517 2521 2517 2521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 2569 2579 2569 2579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 2463 2471 <span type="species:ncbi:9606">patients</span>
We then assessed disease association of the 41 variants of interest, including these 40 SNPs of interest and the MOG51 microsatellite, in a sample set of 239 families using the extended transmission disequilibrium test (ETDT). Without taking linkage disequilibrium with variation at the HLA-DRB1-DQB1 loci into account, 11 SNPs -SNP07 (novel), SNP06 (novel), SNP05 (novel), rs2071652, rs2857767, SNP04 (novel), rs2535260, rs2535261, SNP03 (novel), rs2252734, rs29228 and the MOG51 microsatellite showed evidence of association at a significance level of 5% with MS (data not shown). We then evaluated MS association of these markers in an additional 158 MS families (total n = 397 families). In this larger sample set, 8 markers showed some evidence of association at 5% significance level (Figure 2) with one haplotype defined by variants at rs2071652 (allele C), rs2857767 (allele C) and rs2535260 (allele C) showing the strongest disease association (P = 3.29 x 10-6). This level of significance was slightly lower than that shown by association of HLA-DRB1 (P = 7.9 x 10-7) and -DQB1 in the same sample set (P = 1.3 x 10-7). The transmission data of these variants individually and in the context of the three locus DRB1-DQB1-MOG haplotypes are shown in the online appendix along with the D' values among MOG variants and the various DRB1-DQB1 haplotypes. The eight disease associated variants are essentially part of two main LD blocks formed, on the one hand by rs2071652, rs2857767 and rs2535260 and on the other hand by the other five variants. From these data it is evident that while SNP07, SNP06; SNP04, SNP03 are in positive LD only with the DRB1*0301-DQB1*0201 haplotype, SNPs rs2071652, rs2857767 and rs2535260 occur frequently (albeit at different degrees of positive LD from strong to modest) and show a significant association with more than one HLA-DRB1-DQB1 haplotype. The co-occurrence of these MOG variants with different DRB1-DQB1 haplotypes could just be a chance event or could be due to any of the various forces which impact LD [37]. Importantly, we also assessed the disease association of MOG alleles which individually showed significant evidence of association with MS together with the other DRB1-DQB1 haplotypes grouped (that is, all DRB1-DQB1 haplotypes which did not show any evidence of significant association with MS). These extended DRB1-DQB1-MOG haplotypes showed a consistent negative transmission from parents to affected patients (see Additional file 1). This suggested that MOG disease associations were most likely driven by DRB1-DQB1 variation.
###end p 15
###begin p 16
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
ETDT analysis in 397 MS families. Single-point association of 1 microsatellite and 8 SNP markers with MS within the MOG gene. Distances are given in Kb proceeding from the most centromeric marker, SNP07, to the most telomeric, SNP03. Association is presented as the negative log of the P-value for the extended transmission disequilibrium test (ETDT). The bold horizontal line corresponds to the threshold significance of 0.05
###end p 16
###begin p 17
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 88 98 88 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 388 397 388 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQB1 </italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 498 508 498 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 582 584 582 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 601 603 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3</sup>
Next, we wanted to directly assess whether these MOG associations were independent from DRB1-DQB1 associations. To this end, we analysed the overall effect of allelic and haplotype variation at the MOG gene using the conditional ETDT (CETDT) [38]. Using this conditional analysis, which takes into account linkage disequilibrium between overall MOG variation and overall variation at the HLA-DQB1 and -DRB1 loci, MOG associations were no longer significant. Conversely, the overall associations of DRB1-DQB1 haplotypes, taking into account the most associated MOG haplotype, gave a P value of 9.7 x 10-3.
###end p 17
###begin p 18
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 106 121 106 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQA1-DQB1 </italic>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 323 326 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG</italic>
###xml 380 394 380 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1-DQB1 </italic>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 653 657 653 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 731 741 731 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 773 777 773 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 938 948 938 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 1062 1066 1062 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 1128 1138 1128 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 1209 1219 1209 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 1244 1248 1244 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 1433 1434 1433 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
We also evaluated the relative transmission of the MOG alleles and haplotypes according to which specific DRB1-DQA1-DQB1 haplotypes they were on (Figure 3). In order to carry out these analyses we used the haplotype method (HM)-TDT (Methods) [39]. Using this test we initially evaluated association of specific variants of MOG, taking into account linkage disequilibrium with the HLA-DRB1-DQB1 haplotypes for which there is prior evidence of association with MS in the Sardinian population (i.e. DRB1*1303-DQB1*0301, DRB1*0405-DQB1*0301, DRB1*0301-DQB1*0201, DRB1*1501-DQB1*0602 and DRB1*0405-DQB1*0302 haplotypes) [13]. Again, allelic variation at the MOG locus did not significantly affect the transmission of these predisposing DRB1-DQB1 haplotypes (Figure 3). Also the MOG haplotype defined by rs2071652, rs2857767 and rs2535260 did not produce significant evidence of primary association when analysed with the HM-TDT conditional on DRB1-DQB1 positively associated haplotypes (data not shown). Moreover, we also conducted the HM-TDT to assess whether these MOG variants were influencing association of the non-predisposing DRB1-DQB1 haplotypes grouped. No significant heterogeneity in the association of DRB1-DQB1 haplotype conditional on MOG was seen, again suggesting that the initial observations of association with MS risk were likely to be only a consequence of LD with the DR-DQ mediated MS risk. This is shown in Figure 3, Graph F.
###end p 18
###begin p 19
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 62 72 62 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 176 186 176 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 345 355 345 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 673 674 673 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Association analysis of 8 MOG variants with MS conditional on DRB1-DQB1 haplotypes using the Haplotype Method TDT Association analysis of 8 MOG variants with MS conditional on DRB1-DQB1 haplotypes using the Haplotype Method-Transmission Disequilibrium Test HM-TDT [39]. The 8 MOG variants are the same shown in Figure 1 while the 5 predisposing DRB1-DQB1 haplotypes refer to DRB1*0301-DQB1*0201 (2A), DRB1*0405-DQB1*0301 (2B), DRB1*1303-DQB1*0301(2C), DRB1*0405-DQB1*0302 (2D) and DRB1*1501-DQB1*0602 (2E), with DRB1*-DQB1* families negative for MS haplotypes that showed prior evidence of association with MS (2F) [13]. Association is presented as the negative log of the P-value for the extended transmission disequilibrium test (ETDT). The bold horizontal line corresponds to the threshold significance of 0.05
###end p 19
###begin p 20
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 726 740 726 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1-DQB1 </italic>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Considering our results globally, they provide evidence that haplotypes identical at the DRB1-DQB1 loci but different at the MOG locus do not have different associations with MS. Thus the significant association of MOG alleles and haplotypes appear to be secondary to hitchhiking effects due to variation at the DRB1-DQB1 loci. In interpreting these results it should be considered that the HLA region as a whole confers only a relatively modest contribution to the familial clustering and to the individual inherited risk of MS. Thus, the statistical power required to rule out a rare disease variant not detected in our resequencing, or even more dramatically, one that only slightly modulates the disease risk conferred by HLA-DRB1-DQB1 variants would require unrealistic sample sizes which exceed those used in this study. Still, our results and conclusions are consistent with those obtained in other populations [40], although there is still the suggestion that other non-DR-DQ genes may convey an independent risk to MS [41,42,12,24].
###end p 20
###begin p 21
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 406 409 406 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS</italic>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS </italic>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 209 214 <span type="species:ncbi:9606">human</span>
The genetic results presented here have relevant mechanistic biological implications because they suggest that the protein product of the candidate gene MOG is unlikely to represent the primary autoantigen in human MS and thus cannot explain the target organ specificity observed in this disease. Contrast these data with the primary and consistent association detected with variation in the insulin gene (INS) region in type 1 diabetes and the epistatic deviations from a multiplicative model detected in the joint analysis of HLA class II and INS [43].
###end p 21
###begin title 22
Conclusion
###end title 22
###begin p 23
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 280 285 <span type="species:ncbi:9606">human</span>
From our results we can conclude that variation at the MOG gene does not provide a significant independent contribution to the inherited risk for MS in the Sardinian population. The data suggests that the protein product of MOG is unlikely to represent the primary autoantigen in human MS.
###end p 23
###begin title 24
Methods
###end title 24
###begin title 25
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants
###end title 25
###begin p 26
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 784 799 784 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQA1-DQB1 </italic>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 120 125 <span type="species:ncbi:9606">child</span>
###xml 461 469 <span type="species:ncbi:9606">patients</span>
###xml 725 733 <span type="species:ncbi:9606">patients</span>
In the study we considered a sample set of 397 independent MS families, which included 391 trios families (one affected child and both healthy parents), 4 multiplex families (more than one affected sibling and their healthy parents) and 2 vertical families (one parent and one affected offspring), all being at least third generation Sardinian. This data set of 397 MS families is a proper subset of the 490 Sardinian MS families described previously [13]. All patients met the criteria of definite MS [33]. The average age of onset for MS was 28.9 years (range 6 - 51 years), and the female/male ratio was 2.3. The disease course was relapsing-remitting in 65%, secondary progressive in 27% and primary progressive in 8% of patients. All families had previously been analysed at the DRB1-DQA1-DQB1 loci [13].
###end p 26
###begin title 27
Power calculations
###end title 27
###begin p 28
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 445 455 445 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 622 632 622 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 642 646 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 679 680 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 680 682 680 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 214 219 <span type="species:ncbi:9606">child</span>
To examine the feasibility of verifying whether variants in the MOG gene, or in strong LD with it could explain the association peak that was previously observed in Sardinia [13], we focused on the parent-affected child trios that we had already studied during the initial examination of the role of the HLA in MS susceptibility. We postulated that our search would be for a fairly common variant (in line with the frequency of the predisposing DRB1-DQB1 haplotypes) with a maximal relative risk of 1.9 and using a disease prevalence of 0.0014 (corresponding to the prevalence in Sardinia). The strength of LD between the DRB1-DQB1 locus and MOG was estimated at a mean value of r2 = 0.3 as previously shown [13]. Purcell and Sham power calculations for our 391 trios gave for an alpha value of 0.10 a power of 0.83 [44]. It should be noted that for the conditional analyses, in the case of conditioning on the absence of high-risk HLA haplotypes, the trio size is 121 and the corresponding power is reduced to 0.42 for the same alpha criteria.
###end p 28
###begin title 29
MOG polymorphism analysis
###end title 29
###begin p 30
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG51 </italic>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 557 562 <span type="species:ncbi:9606">human</span>
We resequenced the MOG gene in 21 parents of MS patients heterozygous for the 226 bp allele at the MOG51 microsatellite locus, which was found to be significantly associated with MS [13]. This selection of informative parents increases the chance of detecting relevant polymorphisms. 37 overlapping fragments covering the whole gene (8 exons and 7 introns) and -384 and 545 bp 5' and 3' from the transcriptional unit were amplified and capillary sequenced (Megabace 1000). Overall, 16,561 bp were sequenced. Primers were designed according to the published human genomic DNA sequence [34] and are listed in Table 1). PCR was carried out in a final volume of 25 mul using a specific combination of primers and 5 mul of 4 ng/mul genomic DNA. After an initial denaturation of 4 minutes at 95degreesC, there were 37 cycles at 95degreesC for 30 seconds, at the specific TM primer for 30 s, 72degreesC for 30 s and a final extension at 72degreesC for 7 minutes.
###end p 30
###begin p 31
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
A set of 40 informative SNPs was selected and dot-blot genotyped in the family sample set, using the set of primers listed in Table 1 and the SSO probes reported in Table 2. Selection of these SNPs was based on the patterns of LD (in order to provide good map coverage and avoid genotyping and testing genetically redundant variants), on the position in the gene (in order to maximise the chance of testing functionally relevant variants) and on the minor allele frequency (MAF) (in order to exclude particularly rare variants for which we did not have sufficient statistical power in the subsequent association stage).
###end p 31
###begin p 32
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG51 </italic>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
In addition to these SNPs, in this manuscript we also assessed the association of MS with 1 intragenic microsatellite, MOG51 [34], whose primer sequences have been previously reported [13].
###end p 32
###begin title 33
Statistical analysis
###end title 33
###begin p 34
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 376 378 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 729 732 729 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG</italic>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1</italic>
###xml 882 886 882 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 939 949 939 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1217 1219 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1670 1672 1670 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
Single-point disease association of individual MOG variants as well as HLA-DRB1, DQB1 alleles was evaluated using ETDT [45]. This test takes into account the transmission or non-transmission of alleles of a locus relative to those present on the other parental chromosome. In the case of multiallelic markers, the ETDT takes multiple alleles into account and obtains a global P value indicative of the degree of significance of the association with the disease at each individual locus. In order to distinguish primary associations from those due to linkage disequilibrium at the various assessed loci, we used a variant of the ETDT, called CETDT [38]. This test allows us to analyse the overall effect of one locus, in our case MOG, taking the overall association of variation at other loci into account; in this study DRB1 and DQB1. In order to study the transmission of specific MOG alleles, conditioned on alleles or haplotypes at the DRB1-DQB1 disease loci, we used a TDT variant of the haplotype method [46]; the HM-TDT [39]. This method tests the null hypothesis of equality of transmission of haplotypes identical at one variant or combination of variants, but different at another closely-linked test locus [39]. If there is heterogeneity in the transmission of two marker haplotypes identical at a predisposing marker (variant A) but different at a putative predisposing marker at another site (variant B), then this is evidence that variant A does not entirely explain disease predisposition and that variant B itself, or another marker in linkage disequilibrium with variant B, is influencing the transmission of variant A and, thus, disease susceptibility [39].
###end p 34
###begin p 35
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r2 </italic>
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 355 357 355 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dmax</italic>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 679 681 679 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R2</italic>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 897 899 897 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 941 942 941 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 948 951 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r2 </italic>
###xml 995 998 995 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r2 </italic>
###xml 1286 1287 1286 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1438 1441 1438 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r2 </italic>
###xml 1578 1580 1578 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
LD between individual SNPs at the MOG gene was assessed computing the D' and r2 values. Both measures are built on the basic pairwise-disequilibrium coefficient, D, described by Lewontin [47], representing the difference between the probability of observing two marker alleles on the same haplotype and observing them independently in the population. The D and normalised disequilibrium D', or |D/Dmax|, values were computed on parental haplotypes using the software package [48]. A value of D' equal to 0.0 implies complete independence, whereas 1.0 implies that all copies of the rare allele occur exclusively with one of the two possible alleles at the other assessed marker. R2, computed using a programme written by Jason Cooper, assesses not only LD between two markers but also the degree of matching between all allelic frequencies of both SNPs [49], thus encompassing the effects of both D and all marker allele frequencies. As for D', an r2 value of 0.0 also implies independence, but r2 = 1.0 occurs only when the marker loci have identical allele frequencies and every occurrence of an allele at each of the markers perfectly predicts the allele at the other locus (i.e. in the presence of genetically indistinguishable makers). The two LD measures have different features: D' levels are useful to define the extent of LD, for instance to establish the presence of the so-called LD blocks along chromosome intervals. Instead, r2 are useful to establish marker informativity and the degree of genetic redundancy between selected SNPs and thus determine map coverage [49].
###end p 35
###begin p 36
###xml 358 365 <span type="species:ncbi:9606">patient</span>
For all analyses performed in this manuscript, haplotypes were established following the co-segregation of alleles within families and using computer programmes written by F. Dudbridge and B. Koeleman. Only haplotypes showing definitive parental genotype data are considered in the analyses shown in this paper. In those families with more than one affected patient, only the probands were evaluated.
###end p 36
###begin title 37
Abbreviations
###end title 37
###begin p 38
CETDT: conditional ETDT
###end p 38
###begin p 39
ETDT: extended transmission disequilibrium test
###end p 39
###begin p 40
HM-TDT: haplotype method transmission disequilibrium test
###end p 40
###begin p 41
LD: linkage disequilibrium
###end p 41
###begin p 42
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG</italic>
MOG: Myelin Oligodendrocyte Glycoprotein
###end p 42
###begin p 43
MS: Multiple sclerosis
###end p 43
###begin title 44
Competing interests
###end title 44
###begin p 45
The author(s) declare that they have no competing interests.
###end p 45
###begin title 46
Authors' contributions
###end title 46
###begin p 47
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MGM</bold>
###xml 3 5 3 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1 </bold>
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1 </bold></sup>
###xml 62 64 62 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">FC</bold>
###xml 64 66 64 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3 </bold>
###xml 64 66 64 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>3 </bold></sup>
###xml 94 96 94 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RM</bold>
###xml 96 98 96 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1 </bold>
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1 </bold></sup>
###xml 226 228 226 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GC</bold>
###xml 228 230 228 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1 </bold>
###xml 228 230 228 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1 </bold></sup>
###xml 298 301 298 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MCM</bold>
###xml 301 302 301 302 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1</bold></sup>
###xml 304 306 304 306 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MR</bold>
###xml 306 307 306 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1</bold></sup>
###xml 309 311 309 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LS</bold>
###xml 311 313 311 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1 </bold>
###xml 311 313 311 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1 </bold></sup>
###xml 317 319 317 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ES</bold>
###xml 319 321 319 321 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1 </bold>
###xml 319 321 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1 </bold></sup>
###xml 389 391 389 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SC</bold>
###xml 391 393 391 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1 </bold>
###xml 391 393 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1 </bold></sup>
###xml 445 448 445 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MAS</bold>
###xml 448 450 448 450 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1 </bold>
###xml 448 450 448 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1 </bold></sup>
###xml 535 537 535 537 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EC</bold>
###xml 537 539 537 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1 </bold>
###xml 537 539 537 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1 </bold></sup>
###xml 623 626 623 626 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MBW</bold>
###xml 626 628 626 628 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3 </bold>
###xml 626 628 626 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>3 </bold></sup>
###xml 686 688 686 688 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MP</bold>
###xml 688 689 688 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2</bold>
###xml 688 689 688 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>2</bold></sup>
###xml 691 693 691 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SS</bold>
###xml 693 695 693 695 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2 </bold>
###xml 693 695 693 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>2 </bold></sup>
###xml 699 701 699 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GR</bold>
###xml 701 703 701 703 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2 </bold>
###xml 701 703 701 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>2 </bold></sup>
###xml 823 825 823 825 <bold xmlns:xlink="http://www.w3.org/1999/xlink">FC</bold>
###xml 825 827 825 827 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3 </bold>
###xml 825 827 825 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><bold>3 </bold></sup>
###xml 765 773 <span type="species:ncbi:9606">patients</span>
MGM1 participated in the study design, discussed results with FC3 and reviewed the manuscript.RM1 checked all data files for genotyping problems, performed statistical analysis on the data and designed all figures and tables. GC1 set up and supervised the different protocols and methods performed.MCM1, MR1, LS1 and ES1 performed amplification and re-sequencing of all exons and introns. SC1 completed all DNA extraction from peripheral blood. MAS1 optimised DNA concentration for all samples and prepared all aliquots and dilutions. EC1 organised family selection and maintained contacts with them for sample collection. MBW3 assisted in manuscript revision and statistical analysis. MP2, SS2 and GR2 provided useful suggestions and collected DNA for part of the patients studied together with the related clinical data. FC3 supervised the study, analysed the results and wrote the manuscript. All authors read and approved the final manuscript.
###end p 47
###begin title 48
Supplementary Material
###end title 48
###begin title 49
Additional file 1
###end title 49
###begin p 50
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 73 82 73 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1</italic>
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
###xml 322 336 322 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA DRB1-DQB1 </italic>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MOG </italic>
TDT results for Alleles of the MOG haplotypes treated separately or with DRB1-DQB1. Transmission test for linkage disequilibrium was conducted with each of the alleles for the MOG haplotypes. The column on the left shows the results for each allele singly, while the column on the right shows the transmission results for HLA DRB1-DQB1 when the MOG allele is fixed.
###end p 50
###begin p 51
Click here for file
###end p 51
###begin title 52
Acknowledgements
###end title 52
###begin p 53
We wish to thank Rebecca Lewis for editorial assistance in the preparation of the manuscript and Jason Cooper for providing us with a programme to compute r2 square values. This work was supported by FISM - Fondazione Italiana Sclerosi Multipla - Cod. 2004/R/5.
###end p 53
###begin article-title 54
Clinical feature of multiple sclerosis.
###end article-title 54
###begin article-title 55
The increasing incidence and prevalence of MS in a Sardinian province
###end article-title 55
###begin article-title 56
Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia
###end article-title 56
###begin article-title 57
Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk
###end article-title 57
###begin article-title 58
A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group
###end article-title 58
###begin article-title 59
Multiple sclerosis
###end article-title 59
###begin article-title 60
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course
###end article-title 60
###begin article-title 61
###xml 70 78 <span type="species:ncbi:9606">patients</span>
HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients
###end article-title 61
###begin article-title 62
HLA class II associated risk and protection against multiple sclerosis-a Finnish family study
###end article-title 62
###begin article-title 63
The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen
###end article-title 63
###begin article-title 64
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans
###end article-title 64
###begin article-title 65
A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis
###end article-title 65
###begin article-title 66
Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia
###end article-title 66
###begin article-title 67
HLA-DR15 is associated with lower age at onset in multiple sclerosis
###end article-title 67
###begin article-title 68
HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis.
###end article-title 68
###begin article-title 69
HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews
###end article-title 69
###begin article-title 70
###xml 55 61 <span type="species:ncbi:9103">Turkey</span>
HLA-DR and -DQ associations with multiple sclerosis in Turkey
###end article-title 70
###begin article-title 71
The combination of HLA-DR1 and HLA-DR53 protects against MS
###end article-title 71
###begin article-title 72
###xml 48 54 <span type="species:ncbi:9135">Canary</span>
HLA associations with multiple sclerosis in the Canary Islands
###end article-title 72
###begin article-title 73
DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians
###end article-title 73
###begin article-title 74
Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease
###end article-title 74
###begin article-title 75
A full genome search in multiple sclerosis
###end article-title 75
###begin article-title 76
Association between the ancestral haplotype HLA A30B18DR3 and multiple sclerosis in central Sardinia
###end article-title 76
###begin article-title 77
###xml 152 160 <span type="species:ncbi:9606">patients</span>
Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients
###end article-title 77
###begin article-title 78
###xml 111 121 <span type="species:ncbi:10116">Norway rat</span>
Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response
###end article-title 78
###begin article-title 79
###xml 66 70 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Experimental autoimmune encephalomyelitis induced in B6.C-H-2bm12 mice by myelin oligodendrocyte glycoprotein: effect of MHC class II mutation on immunodominant epitope selection and fine epitope specificity of encephalitogenic T cells
###end article-title 79
###begin article-title 80
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
###end article-title 80
###begin article-title 81
Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis
###end article-title 81
###begin article-title 82
Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation
###end article-title 82
###begin article-title 83
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
###end article-title 83
###begin article-title 84
Lack of association between antimyelin antibodies and progression to multiple sclerosis.
###end article-title 84
###begin article-title 85
Linkage analysis of candidate myelin genes in familial multiple sclerosis
###end article-title 85
###begin article-title 86
Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis
###end article-title 86
###begin article-title 87
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human myelin oligodendrocyte glycoprotein (MOG) gene: complete nucleotide sequence and structural characterization
###end article-title 87
###begin article-title 88
Myelin oligodendrocyte gene polymorphisms and childhood multiple sclerosis
###end article-title 88
###begin article-title 89
Major factors influencing linkage disequilibrium by analysis of different chromosome regions in distinct populations: demography, chromosome recombination frequency and selection
###end article-title 89
###begin article-title 90
Adaptation of the extended transmission/disequilibrium test to distinguish disease associations of multiple loci: the Conditional Extended Transmission/Disequilibrium Test
###end article-title 90
###begin article-title 91
The HLA-DPB1--associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1
###end article-title 91
###begin article-title 92
Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis
###end article-title 92
###begin article-title 93
A second major histocompatibility complex susceptibility locus for multiple sclerosis.
###end article-title 93
###begin article-title 94
###xml 26 31 <span type="species:ncbi:9606">human</span>
Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis
###end article-title 94
###begin article-title 95
Heterogeneity in the magnitude of the insulin gene effect on HLA risk in type 1 diabetes
###end article-title 95
###begin article-title 96
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits
###end article-title 96
###begin article-title 97
An extended transmission/disequilibrium test (TDT) for multi-allele marker loci
###end article-title 97
###begin article-title 98
Detecting disease-predisposing variants: the haplotype method
###end article-title 98
###begin article-title 99
On measures of gametic disequilibrium
###end article-title 99
###begin article-title 100
The complex interplay among factors that influence allelic association
###end article-title 100

